Facilitated By

San Antonio Medical Foundation

Phase I/II a Trial of Folate Binding Protein (FBP) Peptides (E39 and J65) Vaccine in Ovarian and Endometrial Cancer Patients

Cancer Insight, LLC

Cancer Insight is a Texas-based boutique contract research organization (CRO) dedicated to discovering, developing and testing emerging biotechnologies focused on cancer immunotherapy. Founded by industry pioneer Dr.

Principal Investigator(s)
George Peoples
Funded by
Industry Sponsored
Research Start Date

The purposes of the study are as follows: 1) to test the development of a potential anticancer study called E39 peptide vaccine and J65 peptide vaccine; 2) to determine if the study vaccine is safe; 3) to determine the best dose of the study vaccine 4) to learn more about the side effects of the study vaccine and how it affects the immune system; and 5) to determine if folate binding protein expression in tumor is associated with the effectiveness of the vaccine.

Drug Discovery